{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:18:27Z","timestamp":1754144307767,"version":"3.41.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.gastrohep.2025.502347","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:27:28Z","timestamp":1736425648000},"page":"502347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel desensitization therapy of mesalamine intolerance in patients with ulcerative colitis"],"prefix":"10.1016","volume":"48","author":[{"given":"Kenji","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Sawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonoe","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuteru","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Katsurada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2025.502347_bib0145","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0150","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/j.gastro.2018.12.008","article-title":"AGA Technical review on the management of mild-to-moderate ulcerative colitis","volume":"156","author":"Singh","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0155","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/gut.51.4.536","article-title":"Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines","volume":"51","author":"Ransford","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000489878","article-title":"Treatment adherence in patients with ulcerative colitis is dependent on the formulation of 5-aminosalicylic acid","volume":"99","author":"Nakagawa","year":"2019","journal-title":"Digestion"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0165","first-page":"CD000544","article-title":"Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","volume":"8","author":"Murray","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0170","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/gut.37.6.838","article-title":"Mesalazine induced exacerbation of ulcerative colitis","volume":"37","author":"Kapur","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0175","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","article-title":"ECCO Guidelines on inflammatory bowel disease and malignancies","volume":"17","author":"Gordon","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0180","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S2468-1253(20)30012-1","article-title":"Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study","volume":"5","author":"Burisch","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/jgh.15138","article-title":"Multicenter survey on mesalamine intolerance in patients with ulcerative colitis","volume":"36","author":"Hiraoka","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0190","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000527452","article-title":"Significance of 5-aminosalicylic acid intolerance in the clinical management of ulcerative colitis","volume":"104","author":"Mikami","year":"2023","journal-title":"Digestion"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0195","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s12328-020-01246-w","article-title":"Correction to: Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report","volume":"14","author":"Arai","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-019-1049-2","article-title":"The culprit of mesalamine intolerance: case series and literature review","volume":"19","author":"Xie","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0205","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3390\/jcm8122109","article-title":"Switching between three types of mesalazine formulation and sulfasalazine in patients with active ulcerative colitis who have already received high-dose treatment with these agents","volume":"8","author":"Yasutomi","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0210","first-page":"174","article-title":"Long term results of mesalazine desensitization to intolerant patients with inflammatory bowel disease","volume":"2","author":"Fukushima","year":"2020","journal-title":"Br J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0215","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1034\/j.1398-9995.1999.00298.x","article-title":"Desensitization after fever induced by mesalazine","volume":"54","author":"Gonzalo","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0220","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.anai.2017.01.026","article-title":"Mesalamine desensitization in a patient with treatment refractory ulcerative colitis and aspirin and nonsteroidal anti-inflammatory drug hypersensitivity","volume":"118","author":"Heath","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0225","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jaip.2017.08.036","article-title":"A novel 2-day desensitization protocol to oral mesalamine","volume":"6","author":"Panganiban","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0230","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1002\/ibd.21323","article-title":"New desensitization regimen with mesalamine granules in a patient with ulcerative colitis and mesalamine intolerance","volume":"17","author":"Oustamanolakis","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0235","doi-asserted-by":"crossref","first-page":"22176","DOI":"10.1038\/s41598-020-79207-z","article-title":"Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease","volume":"10","author":"Matsumoto","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0240","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D\u2019Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0245","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/apt.16120","article-title":"5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis","volume":"53","author":"Hibiya","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0250","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1590-8658(01)80108-0","article-title":"Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects","volume":"33","author":"Di Paolo","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0255","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bmj.282.6258.110","article-title":"Sulphasalazine desensitisation","volume":"282","author":"Holdsworth","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3164\/jcbn.22-33","article-title":"Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis","volume":"71","author":"Minagawa","year":"2022","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0265","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","article-title":"Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies","volume":"100","author":"Velayos","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0270","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/apt.14023","article-title":"Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"45","author":"Bonovas","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0275","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2222.1997.tb00690.x","article-title":"The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity","volume":"27","author":"Nyfeler","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.gastrohep.2025.502347_bib0280","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5217\/ir.2018.16.2.273","article-title":"Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy","volume":"16","author":"Saito","year":"2018","journal-title":"Intest Res"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:37:19Z","timestamp":1752583039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570525000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0210570525000123"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502347","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel desensitization therapy of mesalamine intolerance in patients with ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502347"}}